Table 3.
Species | Neurologic Signs | Route of Infection | References | |
---|---|---|---|---|
Human | Clinical | Signs: confusion, coma, weakness, drowsiness, irritability Sequelae: behavioral changes, tremors, convulsions, seizures, photophobia, confusion, intellectual disability, irritability, depression, anxiety, paranoia, emotional instability, deficits in hearing and speech, alveolar hypoventilation, sleep apnea |
Aerosol or subcutaneous | [13,14,73,74,75,76,77] |
Mouse | BALB/c | Unspecified signs of encephalitis a | Intranasal (CO92 strain) | [78] |
Succumb prior to neurologic signs a | Aerosol and intranasal | [53,79] | ||
NIH Swiss | Unspecified signs of encephalitis a | Intranasal (CO92 strain) | [78] | |
Succumb prior to neurologic signs a | Intranasal (McMillan and TBT235 strains) | |||
CD-1 | Unspecified signs of encephalitis a | Intranasal (CO92 strain) | [78] | |
C57BL/6 | Unspecified signs of encephalitis a | Intranasal (CO92 strain) | [78] | |
Hamster | Golden Syrian | Succumb prior to neurologic signs a | Intraperitoneal | [70,80] |
Ataxia and neurologic “fits” | Respiratory, intracranial, intraperitoneal, and intradermal | [81] | ||
Guinea pig | unspecified | Succumb prior to neurologic signs a | Intracranial or intraperitoneal | [82] |
Non-human Primate | Cynomolgus Macaques | Reduced activity, tremors, convulsions, reduced response to stimuli, coma | Aerosol | [83] |
No clinical or neurologic signs | Subcutaneous | [42] |